MENU

First Brexit… then Trump… Now, it’s time for Pro

Is your portfolio really prepared for what’s coming next?

To help investors like you navigate this historically uncertain — yet high-flying — market and prepare for an inevitable downturn, we’re re-opening our Motley Fool Pro Canada service to a select few new members for a short time.

To discover how Pro Canada could help you to increase your upside potential… reduce your downside risk… and earn paycheque-like income in the process, simply click here — before the small number of spots we have left are all gone!

Bill Ackman Throws in the Towel on Valeant Pharmaceuticals Intl Inc.

Bill Ackman finally dumped his entire stake in the dreaded Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX). There’s no question that Valeant has been a destroyer of wealth over the last few years, and there are lessons to be learned from Ackman’s sentimental attachment to his losing investment. Valeant shares plunged a whopping 10% on the announcement that Ackman dumped his entire stake, as many of Ackman’s followers are now jumping ship as well.

Bill Ackman stood by Valeant through the downfall and even joined the board of directors to attempt to steer Valeant back in the right direction to recoup Pershing Square Holding Ltd.’s massive losses. Things didn’t work out well, and Valeant kept falling further into the abyss as the debt problems mounted. Valeant is expected to be on damage control for the next few years as it attempts to raise money from the sale of its non-core assets. Valeant probably won’t get a great deal on these sales, because everybody knows the situation Valeant is in; the buyer will be the one with all of the bargaining power.

In a previous piece, I mentioned that Valeant will fail to reinvent itself as a legitimate player in the pharmaceutical space. Sure, the new CEO Joseph Papa has a wealth of experience, but Valeant is a sinking ship, and not even the most qualified man in the world can save this travesty of a company. Charlie Munger referred to Valeant as a sewer a few years back, and he was right on the money.

Valeant is a lost cause, and Ackman knows it. He just got attached to his shares and wanted to salvage what he could. He wasn’t able to salvage anything because the company kept falling by default. There were no catalysts, and investors weren’t buying Ackman’s optimism regarding Valeant.

Ackman could have saved himself and his investors a ton of money if he had discipline and decided to sell when he really realized he’d made a mistake. He admitted his mistake by investing in Valeant a while back, but he decided to hang on to his shares because of his ego.

If you’re ever in a similar situation, when your view of a company has taken a 180-degree turn and you’ve lost all faith in a company, then go with your gut and sell immediately. Don’t hang on with the hopes of a rebound because things could get a lot worse before they get better.

There’s a difference between hanging on to shares because you still believe in the company and hanging on to shares because you just want to get a better price to dump shares of the company you no longer believe in. Stay disciplined, be patient, and don’t get too emotional with your investments. This way you can prevent yourself from pulling a “Bill Ackman.”

Stay smart. Stay hungry. Stay Foolish.

Six "pro" strategies for today's highly uncertain market

Motley Fool Canada's $250,000-real-money-portfolio service, Motley Fool Pro, is currently closed to new members. But lead advisor Jim Gilles is doing something special for investors who are worried about the market and where it will head in 2017.

He's revealing the six strategies he uses in Pro to help members guardrail their portfolios and make money in up, down, and sideways markets.

For a limited time you can download this "Pro 2017 Survival Guide" free of charge by simply clicking here.

Fool contributor Joey Frenette has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

NEW! This Stock Could Be Like Buying Amazon In 1997

For only the 5th time in over 14 years, Motley Fool co-founder David Gardner just issued a Buy Recommendation on this recent Canadian IPO.

Stock Advisor Canada’s Chief Investment Adviser, Iain Butler, also recommended this company back in March – and it’s already up a whopping 57%!

Enter your email address below to claim your copy of this brand new report, “Breakthrough IPO Receives Rare Endorsement.”

I consent to receiving information from The Motley Fool via email, direct mail, and occasional special offer phone calls. I understand I can unsubscribe from these updates at any time. Please read the Privacy Statement and Terms of Service for more information.